HSV encephalitis adjunctive corticosteroid therapy was not associated with lower in-hospital mortality. It also did not improve functional outcomes. Authors said further research is needed.
Key points
Adjunctive corticosteroid therapy not associated with lower in-hospital mortality in HSV encephalitis patients
Adjunctive corticosteroid therapy not associated with better functional outcomes in HSV encephalitis patients
Sources
- Original post
- hubs.la - Linked in the post
APOE4 carriers up to 15-fold higher Alzheimer’s risk
APOE4 carriers can be up to 15 times more likely to develop Alzheimer’s disease compared to those with the most common gene form. The linked article explains the genetic basis and risk levels for single and double APOE4 copies.
Key points
Risk increase: two copies of APOE4 raise risk about 15-fold.
Single copy risk: about two to three times higher than two APOE3 copies.
Sources
Movement Disorders Society Membership – renewal announced
Movement Disorders Society membership renewal is open for 2027. The society reports over 12,000 clinicians, scientists and healthcare professionals as members and offers no-cost membership for eligible individuals from 100+ lower-income countries.
Key points
Membership renewal deadline extended to 2027.
Society membership exceeds 12,000 professionals.
Sources
- Original post
- Membership - Linked page
